» Articles » PMID: 15279638

Pleomorphic Adenoma and Carcinoma Ex Pleomorphic Adenoma: Immunohistochemical Demonstration of the Association Between Tenascin Expression and Malignancy

Overview
Journal Histopathology
Date 2004 Jul 29
PMID 15279638
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: To investigate tenascin expression in salivary gland tumours. Tenascin is a matricellular protein that has been studied in several tumour types. Its expression has been correlated with tumour morphogenesis as well as with local invasiveness and tumour metastatic behaviour.

Methods And Results: The distribution pattern of tenascin in a series of 63 pleomorphic adenomas (PA) and 20 carcinomas ex- pleomorphic adenoma (Ca ex PA) was studied immunohistochemically. Ten normal adult salivary glands were used as controls. Tenascin surrounded the excretory ducts of normal adult salivary gland tissue. It was absent in the basement membrane compartment of both benign and malignant mixed tumours. In the interstitial compartment of the extracellular matrix, the fibro-hyaline type expressed tenascin in a statistically significantly (P < 0.001) lower number of PA cases (25%) in comparison with both malignant and benign areas of Ca ex PA (75% and 90%, respectively). In the Ca ex PA group, a statistically significantly difference (P < 0.001) was found in the frequency of tenascin deposits around aggregates of neoplastic cells between metastasizing (73%) and non-metastasizing neoplasms (0%).

Conclusions: These findings strongly support the hypothesis that tenascin deposition is involved in the mechanisms of malignant transformation of pleomorphic adenomas into carcinomas as well as being associated with clinical disease progression.

Citing Articles

Extracellular matrix remodelling and stiffening contributes to tumorigenesis of salivary carcinoma ex pleomorphic adenoma--A study based on patient-derived organoids.

Chen W, Gu T, Chen Q, Qu C, Zhang C, Hu Y Cell Biosci. 2023; 13(1):122.

PMID: 37393249 PMC: 10315042. DOI: 10.1186/s13578-023-01071-x.


Heterogeneity and versatility of the extracellular matrix during the transition from pleomorphic adenoma to carcinoma ex pleomorphic adenoma: cumulative findings from basic research and new insights.

Scarini J, de Lima-Souza R, Lavareze L, Ribeiro de Assis M, Damas I, Altemani A Front Oral Health. 2023; 4:942604.

PMID: 37138857 PMC: 10149834. DOI: 10.3389/froh.2023.942604.


Immunohistochemical Comparative Study of Aggressive and Non-aggressive Central Giant Cell Lesions of the Jaws Based on the Tenascin-C Expression Profile.

Tobon-Arroyave S, Isaza-Guzman D, Florez-Moreno G J Histochem Cytochem. 2021; 69(7):475-484.

PMID: 34120502 PMC: 8246529. DOI: 10.1369/00221554211025479.


A Review of Selected Factors of Salivary Gland Tumour Formation and Malignant Transformation.

Sowa P, Goroszkiewicz K, Szydelko J, Chechlinska J, Pluta K, Domka W Biomed Res Int. 2018; 2018:2897827.

PMID: 30155477 PMC: 6092996. DOI: 10.1155/2018/2897827.


Loss of heterozygosity occurs predominantly, but not exclusively, in the epithelial compartment of pleomorphic adenoma.

Poetsch M, Zimmermann A, Wolf E, Kleist B Neoplasia. 2005; 7(7):688-95.

PMID: 16026648 PMC: 1501429. DOI: 10.1593/neo.05163.